A shadow market for unlicensed slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.
Investigational Drug Gaining Popularity Via Social Media
The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Followers are urged to message these accounts privately for supplier links, while also receiving promotional offers.
Thriving Trade on Social Networks
Additionally, a robust trade exists on Telegram, where groups with numerous of members share “before and after” images, injection guides and claims of next-day British shipping. Sellers promote the substance there before directing customers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Healthcare Professionals Express Worries
However, doctors and pharmacists have cautions that the sale of what remains an unapproved medication in the United Kingdom is worrisome and could lead to individuals injecting substances of unknown origin.
Some experts stated the popularity for retatrutide could be connected to the rising price of licensed weight loss products such as Mounjaro.
Legal Position and Implementation
Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the British medical regulations.
Several content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach pharmaceutical, marketing, and customer laws, risking fines, legal action or imprisonment.
Platform Response and Material Elimination
According to TikTok, the service has removed violative content and prohibited associated keywords and search suggestions. The organization said it was committed to keeping the service secure and investing in strengthening enforcement strategies.
Digital Trading Operations
Investigations also found communities with up to nine thousand members selling retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, filled with photos of weight loss, glowing reviews and detailed instructions for mixing or administering at residence.
Within minutes of entering one group, a seller shared contact information, where the majority of purchases take place. The vendor provided an guidebook and promised shipping within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about body mass, medical conditions or previous experience.
Product Information and Pricing
Inside these communities, posts display black plastic packages with Royal Mail labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When questioned how long a injector should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Service Moderation and Safety Actions
A representative for Telegram stated it actively monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are administering materials they can’t verify. Even if the science behind this drug is valid, these online versions may not include what they advertise,” stated Jason Murphy, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.
Her staff has previously encountered patients injured by personal administration from unverified sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly experimental substance not yet approved … may expose users to potentially serious health risks”.
